ライフサイエンスコーパス: adolescent

1 n a representative sample of US children and adolescents.

2 general population that includes adults and adolescents.

3 fMRI), to predict the onset of depression in adolescents.

4 weight does not scale with height squared in adolescents.

5 ed as a PTA>25 dB in adults and PTA>15 dB in adolescents.

6 to help reduce excess weight in children and adolescents.

7 the most common bone cancer in children and adolescents.

8 I paradigm in a population-derived sample of adolescents.

9 splatin-induced hearing loss in children and adolescents.

10 he development of smoking in male and female adolescents.

11 important role in safeguarding the trust of adolescents.

12 this does not ensure that BMI is accurate in adolescents.

13 were meta-analysed separately for adults and adolescents.

14 in a nationally representative sample of US adolescents.

15 mptoms in a large population-based sample of adolescents.

16 the design of obesity-preventive programs in adolescents.

17 ciation between GB and OHRQoL in 12-year-old adolescents.

18 roteinase (aMMP)-8 chairside test in Finnish adolescents.

19 ted functional gastrointestinal disorders in adolescents.

20 ten one of the first drugs of abuse tried by adolescents.

21 We randomly assigned 3596 adolescents (10 to 18 years of age) to receive MenB-FHbp

22 ale patient, nearly one third (32%) involved adolescents (13-17 years), most resulted in no (59%) or

23 lth care spending estimates for children and adolescents 19 years and younger in the United States fr

24 129 of adults or unspecified patients, 20 of adolescents, 19 of older patients, and 15 from long-term

25 acy and safety of adalimumab in children and adolescents 2 years of age or older who had active JIA-a

26 The study sample consisted of 499 adolescents [263 (51.8%) girls].

27 linicians screen for obesity in children and adolescents 6 years and older and offer or refer them to

28 y that screening for obesity in children and adolescents 6 years and older is of moderate net benefit

29 Children and adolescents, 6 to 17 years old, with a vitreous haze sco

30 logram per day), and placebo in children and adolescents 8 to 17 years of age with migraine.

31 spital discharge is twice as high as that of adolescents admitted to hospitals for accident-related i

32 This study in juvenile-adolescent aged mice identifies a novel form of synaptic

33 l combination of sofosbuvir and ribavirin in adolescents aged 12-17 with hepatitis C virus genotype 2

34 -fatal self-harm per 100 000 person-years in adolescents aged 12-17 years in England.

35 niversity clinics, we recruited children and adolescents aged 12-17 years with a diagnosis of ICD-10

36 we examined this association in 542 healthy adolescents aged 14 to 18 years old (44.8% African Ameri

37 hairside test was performed on participants (adolescents aged 15 to 17 years), and full-mouth clinica

38 m 564 886 National Pupil Database records of adolescents aged 15 years, living in England, with match

39 Children and adolescents aged 2 to 17 years who resided in Hamilton C

40 Forty-seven children and adolescents aged 5 to 17 years (22 with stuttering and 2

41 and general health outcomes in children and adolescents aged 9 to 15 years.

42 bservational study, we included children and adolescents (aged <18 years) with head injuries of any s

43 We included adolescents (aged 10-19 years) who were admitted as an e

44 rotocol and International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) P1074 multicen

45 xicities or International Maternal Pediatric Adolescent AIDS Clinical Trials P1025 studies.

46 istrative prevalence of ADHD in children and adolescents, an overview of barriers to accessing care,

47 An adolescent and early adulthood dietary pattern character

48 ce, and components of antenatal care between adolescent and older first-time mothers in 13 west Afric

49 ion-based evidence regarding outcomes of the adolescent and young adult (AYA) population with gastroi

50 The treatment of the adolescent and young adult group is delineated, and the

51 At day 7, 78% of adolescents and 35% of children had recombinant vesicula

52 cluded 50 children aged 1 to 9 years and 100 adolescents and adults 15 years and older from each of t

53 1 to 9 years and the prevalence of TT among adolescents and adults 15 years and older.

54 effects of rs9804190 on frontotemporal WM in adolescents and adults with BD and suggest a mechanism c

55 in the United States and Europe for treating adolescents and adults with chronic hepatitis B infectio

56 ongly related to FC between RLPFC and IPL in adolescents and adults, but to frontoparietal SC in chil

57 ators of grief and depression as reported by adolescents and behavioural problems reported by their c

58 At day 2, vaccine RNA titres were higher for adolescents and children than adults.

59 rrently used in adults was well tolerated in adolescents and had an appropriate pharmacokinetic profi

60 hysis, is the most common hip abnormality in adolescents and is a major cause of early osteoarthritis

61 Overweight is epidemic in adolescents and is a major concern because it tracks int

62 bypass with those of conservatively treated adolescents and of adults undergoing Roux-en-Y gastric b

63 to strategically target interventions toward adolescents and rural poor women.

64 unknown whether this relationship extends to adolescents and whether reduced striatal volume prospect

65 To assess the survival impact of SPMs in adolescents and young adults (AYAs) (15-39 years) compar

66 n part to the unique developmental issues of adolescents and young adults as well as the complexity a

67 The prevalence of type 2 diabetes in adolescents and young adults is dramatically increasing.

68 ng of the causes of the survival gap between adolescents and young adults with sarcomas will help dri

69 Incentives to Improve Glycemic Control Among Adolescents and Young Adults With Type 1 Diabetes (BE IN

70 Among adolescents and young adults with type 1 diabetes, daily

71 h 9 met inclusion criteria (comprising 17389 adolescents and young adults).

72 gh as that of group A Streptococcus (GAS) in adolescents and young adults.

73 We primarily report the comparison between adolescents and young adults.

74 ations for gonadotoxicity in male childhood, adolescent, and young adult (CAYA) cancer survivors.

75 ubstantially higher if unvaccinated infants, adolescents, and adult populations were also considered.

76 g for celiac disease in asymptomatic adults, adolescents, and children 3 years and older for the US P

77 with the greatest DALY burdens in children, adolescents, and the elderly.

78 e the most common CNS tumors in children and adolescents, and they show an extremely broad range of c

79 Patients of interest included children, adolescents, and young adults 10 years or older.

80 y, diverse, longitudinal cohort of children, adolescents, and young adults and to test for difference

81 nicity of moxetumomab pasudotox in children, adolescents, and young adults with ALL (N = 55).

82 compared with injection therapy in children, adolescents, and young adults with type 1 diabetes.

83 with insulin injection therapy in children, adolescents, and young adults with type 1 diabetes.

84 authors tested how brain reward learning in adolescent anorexia nervosa changes with weight restorat

85 Reward system responsiveness is elevated in adolescent anorexia nervosa when underweight and after w

86 nce; and (4) final additional adjustment for adolescent antisocial behaviour and substance use measur

87 Adolescents are at the highest risk of death from anaphy

88 ven the many environmental changes that late adolescents are encountering that could be environmental

89 y of mental health services for children and adolescents are needed.

90 Moreover, TMI diagnoses adolescents as overweight more accurately than BMI z sco

91 Moreover, TMI misclassified adolescents as overweight vs normal weight less often th

92 h, are associated with the risk of child and adolescent asthma hospitalization, particularly in indiv

93 itudinal design to track 144 novelty-seeking adolescents at age 14 and 16 to determine whether neural

94 NAFLD was diagnosed in 15.2% of adolescents at age 17 years.

95 ov 30, 2014, we analysed 20 137 children and adolescents attending with head injuries.

96 alarming link with both the structure of the adolescent brain and school performance, and thus highli

97 of Delta(9)-tetrahydrocannabinol in juvenile-adolescents, by potentially altering reward behavioral o

98 eferent date and birth between childhood and adolescent cancer survivors and an age-matched compariso

99 nt study sought to develop a rodent model of adolescent cannabinoid self-administration (SA), using t

100 r their specific provisions did not increase adolescent cannabis use.

101 essing, and brain plasticity, which underlie adolescents' capacity to learn from and adapt to their c

102 opean Union (EU), including legal aspects of adolescent care.

103 ed sequencing study of ADHD in 152 child and adolescent cases and 188 controls across an a priori set

104 s the extent to which depressive symptoms in adolescents change after contact with mental health serv

105 describe a distinct "endophenotype" in obese adolescents characterized by a thin superficial layer of

106 When measured together, adolescent cognitive ability and FCA identified four dev

107 se associations but a further adjustment for adolescent common mental disorders substantially attenua

108 3597 (41%) of 8741 adolescents compared with 8202 (47%) of all 17 386 women

109 The overall attempt model revealed adolescent consultation with a fertility specialist (OR,

110 80 matched adolescent controls and 81 matched adult controls were e

111 infections were reported in 726 children and adolescents, corresponding to a prevalence of 4.2% (95%

112 between DGF and graft loss in pediatric and adolescent deceased donor kidney transplant recipients a

113 There are multiple pathways to first-onset adolescent depression in individuals at familial risk.

114 Industry-sponsored child and adolescent depression trials suffer from a number of imp

115 ant reward processing in the pathogenesis of adolescent depression.

116 the combined effects of chronic illness and adolescent development.

117 rsing care and research should focus more on adolescents' developmental wellbeing, promote peer suppo

118 for premenopausal breast cancer of 1.35 for adolescent diet [95% confidence interval (95% CI), 1.06-

119 rospective studies have examined the role of adolescent diet in breast cancer risk.

120 Adolescents discharged after adversity-related injury ha

121 Adolescent e-cigarette users had increased rates of chro

122 se and synthesise primary research exploring adolescents' experiences of living with sickle cell dise

123 se factors in 168 HIV-negative South African adolescent females aged 16 to 22 years.

124 ed with NAFLD after adjusting for obesity in adolescent females included maternal obesity (odds ratio

125 benefits or harms of screening children and adolescents for excess weight.

126 We analysed data for 17 273 children and adolescents from 29 countries.

127 g a handle dynamometer on 1,950 children and adolescents from Colombia, using MS relative to weight (

128 eport on High Blood Pressure in Children and Adolescents from the National High Blood Pressure Educat

129 ing whole-cell electrophysiology in juvenile-adolescent GAD67-GFP male mice, we examined excitatory p

130 Adolescents gained 32.7% to 35.8% of maximal observed WB

131 ry of the association between early ACEs and adolescent general and emotional health outcomes.

132 e to recommended amounts with dairy foods in adolescent girls with habitually low calcium intakes wou

133 middle income covering the majority of these adolescents globally to derive estimates of investment r

134 ty is higher than previously recognised; the adolescent growth spurt (10-14 years), when substantial

135 n populations, we compared the timing of the adolescent growth spurt's peak height velocity to normal

136 ans are one of the few species undergoing an adolescent growth spurt.

137 Non-Hispanic black children and adolescents had a consistently lower HEI-2010 than that

138 Across west Africa, 5430 (62%) of 8741 adolescents had four or more antenatal care visits compa

139 shRNA in the dentate gyrus of presymptomatic adolescent hAPP mice was sufficient to protect these mic

140 fect of dairy food on weight and body fat in adolescents have been reported to our knowledge.The aim

141 Children and adolescents have poorer HIV treatment outcomes than adul

142 more beneficial than placebo in children and adolescents; however, the benefit is small and disorder

143 Psychological counselling of children and adolescents in an active state of IBD seem to be advised

144 cyberbullying and traditional bullying among adolescents in England, and assess its relative effects

145 the psychological health of bereaved female adolescents in South Africa.

146 oss-sectional data from 5,187 adults and 853 adolescents in the Korean National Health and Nutrition

147 Each year 5.4 million children and adolescents in the United States suffer from dental infe

148 leading public health and social problem for adolescents in the United States.

149 Adults and adolescents increasingly view cannabis as harmless, and

150 1277 adults or adolescents infected with HIV in whom first-line ART had

151 Adolescent intermittent ethanol (AIE) exposure compromis

152 Obesity in children and adolescents is associated with morbidity such as mental

153 c cigarette (e-cigarette) use (vaping) among adolescents is associated with the initiation and progre

154 , such that the high disease burden found in adolescents is often due to accumulation of infections w

155 vice contact and subsequent mental health in adolescents is scarce, and previous findings are mixed.

156 ng mouse-sensitized and exposed children and adolescents is unknown.

157 uction treatment of IL-2RAb in pediatric and adolescent kidney transplant recipients is associated wi

158 We speculate that female adolescents living in high-inequality neighborhoods and

159 -related decreases in cortical thickness, in adolescents living in neighborhoods with differing level

160 olescence affects adult behavior, we exposed adolescent male and female C57BL/6J mice to chronic unpr

161 timate the prevalence of sperm banking among adolescent males newly diagnosed with cancer and to iden

162 g marijuana for recreational use on rates of adolescent marijuana use is a topic of considerable deba

163 the Pediatric HIV/AIDS Cohort Study (PHACS) Adolescent Master Protocol and International Maternal Pe

164 These findings suggest that adolescents may not benefit from high stakes to the same

165 lts and exposure to environmental cadmium in adolescents may play a role in the risk of hearing loss.

166 The sample included 10073 adolescents (mean [SD] age, 15.2 [1.50] years; 49.0% fem

167 Participants were recruited from adolescent medicine clinics and their community partners

168 Adolescent Medicine Trials Network for HIV/AIDS Interven

169 Adolescent Medicine Trials Network for HIV/AIDS Interven

170 g with changes in sexual risk behavior among adolescent men who have sex with men (MSM).

171 The WHO Child and Adolescent Mental Health Atlas, published in 2005, repor

172 ar to be largely accounted for by concurrent adolescent mental health disorders and substance use.

173 ACT) at 15 National Health Service child and adolescent mental health service (CAMHS) clinics in thre

174 , published in 2005, reported that child and adolescent mental health services (CAMHS) in Europe diff

175 mary glucocorticoid corticosterone (CORT) in adolescent mice recapitulates multiple neurobehavioral c

176 undergoing Roux-en-Y gastric bypass, in the Adolescent Morbid Obesity Surgery (AMOS) study.

177 yzed GlyR currents in several regions of the adolescent mouse forebrain (striatum, prefrontal cortex,

178 nistic insight into the vulnerability of the adolescent mPFC towards nutritional stress, such as HFDs

179 terventions 113 enrolled a diverse sample of adolescent MSM at risk for HIV who consented to study pa

180 mma response levels were analyzed in healthy adolescents, Mtb-unexposed control subjects, and patient

181 Adults/adolescents (N = 1071) were randomized to receive either

182 nvironment and neurocognitive development in adolescents' natural resilience to substance use disorde

183 ence of the global rise in the prevalence of adolescent obesity, an unprecedented phenomenon of type

184 with NAFLD in male offspring independent of adolescent obesity.

185 y-related characteristics and NAFLD in 1,170 adolescent offspring aged 17 years participating in the

186 opmental pathways that lead to first-episode adolescent-onset MDD (incident cases) in those at high f

187 us testing of different pathways to incident adolescent-onset MDD composed of contributions from fami

188 cant independent clinical antecedents of new adolescent-onset MDD, but disruptive behavior (beta = -0

189 The phenotype is characterized by adolescent-onset progressive spastic ataxia with frequen

190 ors including past nonadherence and being an adolescent or young adult.

191 h results were limited to infants, children, adolescents, or young adults when possible.

192 or frequency dependence between children and adolescents (P = .38, P = .99, P = .14, and P = .30, res

193 eep homeostasis and circadian amplitude make adolescents particularly sensitive to effects of light c

194 ypothetical case example of a Middle Eastern adolescent patient with incurable cancer and conducted a

195 Fifty-five adolescent patients (27 males, 28 females) with a mean (

196 Adolescent patients (aged 11-17 years) with a diagnosis

197 he strongest effects were found in recurrent adolescent patients.

198 as also unrelated to academic performance in adolescents (per 100-g increase in birth weight, -0.004

199 ate demands on good diet and health; and the adolescent phase of growth and consolidation (15-19 year

200 ipants who had reported self-harm during the adolescent phase of the study (n=135) than in those who

201 ich have not been previously reported in the adolescent population, detected abnormal macular thinnin

202 research center, the Department of Child and Adolescent Psychiatry at New York University Langone Med

203 cross-sectionally to the study of child and adolescent psychopathology, the nature of the relationsh

204 In toluene treated adolescent rats, layer 5/6 NAcc projecting PRL (PRL5/6)

205 We have previously reported that in juvenile/adolescent rats, vitamin D supplementation protects from

206 visits to antenatal care, 2779 (51%) of 5430 adolescents received all the antenatal care components e

207 METHOD: Participants were community adolescents recruited as part of the European IMAGEN stu

208 d the IDF criteria to 1,162 overweight/obese adolescents recruited during 1998-2000 from pediatric cl

209 Caregivers and adolescents reported contact with mental health services

210 Adolescents represent a key population for implementing

211 Adolescents require 8 to 10 hours of sleep per night, al

212 roups-younger children (aged </=6 years) and adolescents requiring transition of care from child to a

213 Further adjustment for adolescent risky substance use and antisocial behaviour

214 ief Problem Monitor-Parent Form to report on adolescent's behaviour in the previous 4 weeks.

215 ell disease impacts on multiple facets of an adolescent's life.

216 elopment and Well-Being Assessment and SDQ), adolescent self-reports of ADHD symptoms on the SDQ, and

217 Adolescents self-reported depressive symptoms (Mood and

218 ting model differed between age groups, with adolescents showing more conservative updating.

219 Our findings thus help to specify adolescent-specific social learning processes.SIGNIFICAN

220 ndings suggests investment in evidence-based adolescent substance use prevention programs in any addi

221 the association was the same in newborns and adolescents, suggesting persistence of signals.

222 We aimed to compare 5-year outcomes of adolescent surgical patients after Roux-en-Y gastric byp

223 s varied less with frequency in children and adolescents than in adults (analysis of variance, P = .0

224 therapy are much lower in older children and adolescents than in adults.

225 non-allergic rhinitis and more pronounced in adolescents than in young children, highlighting the nee

226 atisfied is lower among rural poor women and adolescents than WRAU, although higher among unmarried w

227 In adolescents, these points were 0.440 and 0.447 in girls

228 the 1995-2008 National Longitudinal Study of Adolescent to Adult Health, we applied conventional meth

229 data from the National Longitudinal Study of Adolescent to Adult Health, we test whether the health b

230 other chronic illnesses and collaborate with adolescents to ensure service development are developmen

231 t for obesity and overweight in children and adolescents to inform the US Preventive Services Task Fo

232 ary period for experience to influence their adolescent trajectory and predispose to or protect again

233 The goals were addressed in the Adolescent Trials Network, with protocols implemented in

234 2865 adolescent twins (18-19-years old) from the Twins Early

235 N = 100 monozygotic (genetically identical), adolescent twins.

236 Although overall still a rare disease, adolescent type 2 diabetes now poses major challenges to

237 nes, and environmental factors contribute to adolescent-typical reward-associated behaviors with a pa

238 805 patients (1733 adults and 72 children or adolescents) underwent randomization to receive either e

239 ored among harder-to-reach groups (including adolescents, unmarried and rural poor women), key to und

240 Although a large percentage of west African adolescents use some antenatal care for their first birt

241 e cortex appears most tightly related to the adolescents' variations in sleep habits, as its volume c

242 c, neuroimaging and behavioral data from 132 adolescents, we demonstrate that changes in gene methyla

243 Of these adolescents, we excluded 40 549 (10.4%) girls, 56 107 (8

244 re and total body fat distribution] of these adolescents were collected by trained data collectors.

245 A total of 1,134 adolescents were evaluated for clinical and subjective v

246 Three-quarters of adolescents were on stable ART at transfer, of whom 74%

247 Adolescents who are sexual minorities experience elevate

248 Analysis included 382 adolescents who completed both surveys (193 participants

249 We excluded adolescents who did not have their sex recorded, died du

250 ntion-to-treat population, the percentage of adolescents who had an increase in the hSBA titer by a f

251 14-year-old adolescents who had contact with mental health services

252 Adolescents who had more severe ADHD symptoms as childre

253 Among the additional group of 4800 adolescents who had only self-reported food allergy stat

254 e study (reported here), we enrolled healthy adolescents who had received three doses of 120 mug biva

255 oosing among antipsychotics for children and adolescents who often require chronic treatment.

256 Of 361 children and adolescents who were randomized (mean [SD] age, 9.8 [3.2

257 king were observed in both cohorts for those adolescents whose parents separated (for ALSPAC, odds ra

258 Both 2-h and 6-h adolescent WIN SA groups exhibited significantly better

259 nical symptoms and cognition in children and adolescent with ADHD; and (2) case-control studies asses

260 th mental health services at age 14 years by adolescents with a mental disorder reduced the likelihoo

261 study, we evaluated the efficacy of PENFS in adolescents with abdominal pain-related functional gastr

262 Adolescents with ADHD get licensed less often and at an

263 in blood and buccal tissues of children and adolescents with ADHD.

264 In children and adolescents with and without ASD, we computationally mod

265 Of the estimated 36 000 children and adolescents with asthma in Hamilton County (approximatel

266 ng mouse-sensitized and exposed children and adolescents with asthma.

267 es the need for long-term clinical trials in adolescents with at least 5 years of follow-up data that

268 icacy and safety of ledipasvir-sofosbuvir in adolescents with chronic HCV genotype 1 infection.

269 -sofosbuvir was highly effective at treating adolescents with chronic HCV genotype 1 infection; the d

270 mparative studies that enrolled children and adolescents with confirmed diagnoses of panic disorder,

271 Lymphocyte subpopulations of 40 children and adolescents with Down syndrome and 51 controls were quan

272 In this single-center trial, children and adolescents with drug-resistant epilepsy who had undergo

273 eatment may improve seizures in children and adolescents with drug-resistant epilepsy, but additional

274 to social-emotional stimuli, particularly in adolescents with externalizing symptoms.

275 pine-ER) versus aripiprazole in children and adolescents with first-episode psychosis, to determine w

276 Adolescents with GB showed significantly poorer OHRQoL t

277 In response to the social-emotional stimuli, adolescents with high levels of conduct or hyperactivity

278 y and Safety of Rosuvastatin in Children and Adolescents With Homozygous Familial Hypercholesterolemi

279 Children and adolescents with inflammatory bowel disease (IBD) report

280 or psychological therapy, alongside CBT, for adolescents with moderate to severe depression who are a

281 Adolescents with NAFLD also had a higher amount of total

282 mong adolescents with the condition and with adolescents with other chronic illnesses and collaborate

283 's Hospital, Boston, Massachusetts, among 38 adolescents with overweight or obesity who reported drin

284 ducing diet did not affect body weight among adolescents with overweight or obesity.

285 Lower mean (SE) IQ was observed among adolescents with past-year bipolar disorder (94.2 [1.69]

286 Sixteen adolescents with SCD, aged 10-19 years (mean age 14.9 ye

287 (OCT-A) detect more-frequent retinopathy in adolescents with SCD.

288 gery could be a cost-effective treatment for adolescents with severe obesity if assessed over a time

289 Bariatric surgery for the treatment of adolescents with severe obesity is becoming more common,

290 acy and safety of adalimumab in children and adolescents with severe plaque psoriasis.

291 ckle retinopathy reportedly occurs in 10% of adolescents with sickle cell disease (SCD).

292 For example, among adolescents with specific phobia, those with severe diso

293 ellbeing, promote peer support network among adolescents with the condition and with adolescents with

294 ce imaging (MRI) to compare 103 children and adolescents with TS to a well-matched group of 103 child

295 We screened 4407 adolescents with type 1 diabetes between the ages of 10

296 Among adolescents with type 1 diabetes, rapid increases in alb

297 nd hospital-based mental health services for adolescents, with greater investment in school-based pre

298 s index (BMI) is used to diagnose obesity in adolescents worldwide, despite evidence that weight does

299 Analyses in the AA adolescent/young adult (offspring from COGA families) su

300 lved 975 hemodynamically stable children and adolescents younger than 18 years treated for blunt tors